Differential production of IL-10 by T cells and monocytes of HIV- infected individuals: Association of IL-10 production with CD28-mediated immune responsiveness

Clinical and Experimental Immunology

Volumn 114, Issue 1, 1998, Pages 78-86

  Kumar, A ^a,b   Angel, J B ^b   Daftarian, M P ^b   Parato, K ^b   Cameron, W D ^b   Filion, L ^b   Diaz Mitoma, F ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

CD28; HIV 1; IL 10

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; PHYTOHEMAGGLUTININ;

ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD28; CELL DIVISION; CELLS, CULTURED; DOWN-REGULATION; HIV INFECTIONS; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MITOGENS; MONOCYTES; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES;

EID: 0031693003     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00689.x     Document Type: Article

References (59)

1. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384:529-34.
2. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993; 57:183-289.
3. Giorgi JV, Fahey JL, Smith DC, Hultin LE, Cheng HL, Mitsuyasu RT, Detels R. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987; 138:3725-30.
4. Clerici M, Herkin FT, Venzon DJ, Blatt S, Hendrix GW, Wynn T, Shearer GM. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91:789-95.
5. + cell numbers and clinical staging. J Clin Invest 1989; 84:1892-9.
6. Bell SJ, Cooper DA, Kemp BE, Doherty RR, Penny R. Heterogenous effects of exogenous IL-2 on HIV-specific cell mediated immunity (CMI). Clin Exp Immunol 1992; 90:6:-12.
7. Shearer GM, Clerici M. T helper cell immune dysfunction in asymptomatic, HIV-seropositive individuals: the role of TH1-TH2 cross regulation. Chem Immunol 1992; 54:21-43.
8. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994; 15:321-31.
9. Linette GP, Hartzman RJ, Ledbetter JA, June CH. HIV-1 infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. Science 1988; 241:573-6.
10. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly R-P, Finkel TH. Cross linking CD4 by human immunodeficiency virus gp120 primes T cells for activation induced apoptosis. J Exp Med 1992; 176:1099-106.
11. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J Infect Dis 1994; 169:730-8.
12. Roos MThL, Miedema F, De Meinesz AAP, Leeuw NASM, Pakker NG, Lange JMA, Coutinho RA, Schellekens PThA. Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression. Clin Exp Immunol 1996; 105:409-15.
13. + T cells from human immunodeficiency virus type-1 infected donors. Proc Natl Acad Sci USA 1993; 90:11094-8.
14. + T cells down regulates the expression of CD28: effect on T cell activation and cytokine production. Clin Immunol Immunopathol 1995; 77:262-70.
15. + lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol 1996; 105:220-4.
16. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up regulation of B-7 expression. J Immunol 1993; 151:1224-31.
17. de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
18. Howard M, O'Garra A, Ishida H, de Waal Malefyt R, de Vries J. Biological properties of interleukin 10. J Clin Immunol 1992; 12:239-47.
19. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
20. + T cells. J Exp Med 1994; 184:19-29.
21. Bacchetta R, Bigler M, Touraine J-L, Parkman R, Tovo P-A, Abrams J, de Waal Malefyt R, Roncarolo M-G. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179:493-502.
22. Saville MW, Taga K, Foli A, Broder S, Tosato G, Yarchoan R. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophages lineage. Blood 1994; 83:3591-9.
23. Akridge RE, Oyafuso LK, Reed SG. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 1994; 153:5782-9.
24. Clerici M, Wynn TA, Berzofsky JA et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the immunodeficiency virus. J Clin Invest 1994; 93:768-75.
25. Diaz-Mitoma F, Kumar A, Karimi S, Kryworuchko M, Daftarian MP, Creery WD, Filion L, Cameron W. Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin Exp Immunol 1995; 102:31-39.
26. Daftarian MP, Diaz-Mitoma F, Creery WD, Cameron W, Kumar A. Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferate responses to recall antigens. Clin Diagn Lab Immunol 1995; 2:712-8.
27. Meyaard L, Hovenkamp E, Keet IPM, Hooibrink B, de Jong IH, Otto SA, Miedema F. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J Immunol 1996; 157:2712-8.
28. Emilie D, Fior R, Llorente L et al. Cytokines from lymphoid organs of HIV infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol Rev 1994; 140:5-34.
29. Graziosi C, Pantalea G, Gantt KR, Fortin JP, Demarest J-F, Cohen OJ, Sekaly R-P, Fauci AS. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 1994; 265: 248-52.
30. Maggi E, Mazzetti M, Ravina A et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994; 265:244-8.
31. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor R, Sennelier J, Trinchieri G. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J Exp Med 1994; 179:1351-66.
32. Romagnani S, Del Prete G, Manetti R et al. Role of TH1/TH2 cytokines in HIV infection. Immunol Rev 1994; 140:73-92.
33. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435-42.
34. + T cells from human immunodeficiency virus infected persons. J Exp Med 1995; 182:1759-67.
35. Coligan JE, Konisbee AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. New York: John Wiley & Sons, 1992.
36. Daftarian MP, Kumar A, Kryworuchko M, Diaz-Mitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α. J Immunol 1996; 157:12-20.
37. Thiele DL, Lipsky PE. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J Immunol 1996; 136:1038-48.
38. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71:1065-8.
39. Brodie SJ, Sasseville VG,. Reimann KA, Simon MA, Sehgal PK, Ringler DJ. Macrophage function in simian AIDS. Killing defects in vivo are independent of macrophage infection, associated with alterations in Th phenotype, and reversible with IFN-γ. J Immunol 1994; 153:5790-801.
40. Yoo J, Chen H, Kraus T, Hirsch D, Polyak S, George I, Sperber K. Altered cytokine production and accessory cell function after HIV-1 infection. J Immunol 1996; 157:1313-20.
41. Kootstra NA, van'T Wout AB, Huisman HG, Miedema F, Schuitemaker H. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J Virol 1994; 68:6967-75.
42. Gutheil WG, Subramanyam M, Flentke GR, Sanford DG, Munoz E, Huber BT, Bachovchin WW. Human immunodeficiency virus type 1 tat binds to dipeptidyl aminopeptidase 10 (CD26): a possible mechanism for tat's immunosuppressive activity. Proc Natl Acad Sci USA 1994: 91:6594-8.
43. Niedermann TM, Garcia JV, Hastings WR, Luria S, Ratner L. Human immunodeficiency virus type 1 nef protein inhibits NF-kappa B induction in human T cells. J Virol 1992; 66:6213-9.
44. Luria S, Chambers I, Berg P. Expression of the type 1 human immunodeficiency virus nef protein in T cells prevent antigen receptor mediated induction of interleukin-2 mRNA. Proc Natl Acad Sci USA 1991; 88:5326-30.
45. Gerard C, Bruyns C, Marchant A et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxaemia. J Exp Med 1993; 177:547-50.
46. Silva JSP, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin-10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992; 175:169-74.
47. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993; 150:4754-65.
48. Creery D, Diaz-Mitoma F, Filion L, Kumar A. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur J Immunol 1996; 26:1273-7.
49. Kubin M, Kamoun M, Trinchieri G. Interleukin-12 synergizes with B7/ CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 1994; 180:211-22.
50. Cayotta A, Vuillier F, Siciliano J, Dighiero G. Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients. Int Immunol 1994; 6:611-21.
51. Meyaard L, Kuiper H, Otto SA, Wolthers KC, van Lier RA, Miedema F. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals. Eur J Immunol 1995; 25:232-7.
52. Noel PJ, Boise LH, Green JM, Thompson CB. CD28 costimulation prevents cell death during primary T cell activation. J Immunol 1996; 157:636-42.
53. Corry DB, Reiner SL, Linsley PS, Locksley RM. Differential effects of blockade of CD28-B7 on development of Th1 or Th2 effector cells in experimental Leishmaniasis. J Immunol 1994; 153:4142-8.
54. Sayegh MH, Akalin E, Hancock WW, Russel ME, Carpenter CB, Linsley PS, Turka LA. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181:1869-74.
55. + cells. Eur J Immunol 1995; 25:587-95.
56. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 1996; 272:1939-43.
57. Asjo B, Cefai D, Dehre P, Dudoit Y, Autran B. A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes. J Virol 1993; 67:4395-8.
58. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995; 81:979-82.
59. Angel JB, Kumar A, Parato K et al. Rapid and sustained improvement in cell mediated immune responses during potent anti-HIV therapy with ritonavir and saquinavir. J Infect Dis 1998; 177:898-904.